Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes
Type2 Diabetes, Coronary Heart Disease
About this trial
This is an interventional prevention trial for Type2 Diabetes focused on measuring coronary artery calcium score, type 2 diabetes, coronary heart disease
Eligibility Criteria
Inclusion Criteria:
more than 40 years old T2DM patients have any one cardiovascular risk as follows
- total cholesterol>200mg/dl or low density lipoprotein (LDL) >100mg/dl
- blood pressure>140/90mm/Hg or taking anti-hypertension agents
- history of smoking
- family history of early coronary heart diseases
- proteinuria
Exclusion Criteria:
history of cardiovascular diseases such as coronary heart disease, stroke, heart failure etc, pregnant
Sites / Locations
- Lo-Tung Poh-Ai Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
coronary artery calcium-guide
usual care
1500 asymptomatic T2DM patients who will receive Coronary artery calcium (CAC) imaging using 256 sliced multi-detector computerized tomography (MDCT) scanner If CAC score >0, Treadmill ECG or Thallium201 Scan would be arranged. If Treadmill ECG or Thallium201 show significant ischemia, further study such as CT angiography or coronary angiography will be arranged. If CAC score > 100, Aspirin 100mg QD will be suggested to decrease the cardiovascular risk in patients with low risk of bleeding. Previous studies revealed aspirin for patients with CAC score>100 at low bleeding risk indicated net benefit If CAC score > 400,statin therapy will be suggested to control lipidemia aggressively and target LDL level<70 mg/dL
The investigators will enroll 500 age, gender, risk factor matched T2DM patient from our hospital. The doctor in charge will give usual care according to the Diabetes associate of Taiwan clinical practice guidelines for diabetes care.